Can Amida’s Saraswati end the annual HEDIS scramble for health plans?
Amida’s Saraswati brings near-real-time HEDIS measurement to health plans, but adoption will depend on data quality, integration and trust.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
Can Eurofins Viracor’s BKV inSIGHT panel solve a dangerous kidney transplant monitoring blind spot?
Eurofins Viracor launches BKV inSIGHT for BK virus T-cell monitoring, but adoption will depend on validation and treatment-guidance evidence.
Medical Devices & Diagnostics
Can CoSara’s 30-minute PCR platform close India’s tuberculosis testing gap? The decisive studies have begun
CoSara begins India clinical studies of Co-Diagnostics’ rapid tuberculosis PCR test, but assay clearance and real-world validation remain ahead.
Medical Devices & Diagnostics
CareDx shares have doubled in 2026. Will July 30 earnings support the surge?
CareDx reports Q2 results on July 30 as investors assess transplant testing growth, Medicare coverage clarity and the Naveris strategy.
Medical Devices & Diagnostics
What will Marquis MD’s Boca Raton concierge medicine membership include?
Marquis MD plans an August Boca Raton launch with premium primary care, pediatrics and advanced diagnostics. See what will test the model.
Medical Devices & Diagnostics
Could Ultromics EchoGo improve early detection of heart failure with preserved ejection fraction?
Ultromics’ EchoGo model suggests earlier HFpEF detection, but prospective evidence will decide whether hospitals realize the projected gains.
Medical Devices & Diagnostics
Cizzle Bio launches CIZ1B lung cancer blood test in limited Texas commercial rollout
Cizzle Bio launches CIZ1B in Texas as a lung cancer blood test, with wider adoption hinging on clinical validation and reimbursement.
Medical Devices & Diagnostics
CONMED’s AirSeal gains a crucial da Vinci 5 fit, but will hospitals change their robotic workflow?
See how CONMED’s AirSeal expansion to da Vinci 5 hex cannulas could influence robotic surgery workflows, adoption and recurring sales.
Medical Devices & Diagnostics
Johnson & Johnson has entered soft-tissue robotics, but can Ottava loosen da Vinci’s grip?
Johnson & Johnson can launch its table-integrated Ottava surgical robot in the United States, opening a new competitive front against Intuitive Surgical and Medtronic.
Medical Devices & Diagnostics
How Science Corporation’s PRIMA system restores prosthetic central vision in advanced AMD
Science Corporation launches CE-marked PRIMA in Europe, but reimbursement, specialist training and real-world outcomes will determine access.